Lidocaine topical - Crescita Therapeutics

Drug Profile

Lidocaine topical - Crescita Therapeutics

Alternative Names: Lidocaine topical spray - Crescita Therapeutics; NRI-ANA

Latest Information Update: 18 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nuvo Research
  • Developer Crescita Therapeutics
  • Class Acetanilides; Analgesics; Class Ib antiarrhythmics; Local anaesthetics; Nonsteroidal anti-inflammatories; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 18 May 2016 Chemical structure information added
  • 12 May 2016 Discontinued - Phase-I for Pain in Canada (Topical)
  • 05 Oct 2015 Lidocaine topical is available for licensing as of 20 Aug 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top